LTR Pharma Limited (ASX:LTP)
Australia · Delayed Price · Currency is AUD 0.3917
-0.0183 (-4.46%)
At close: Jul 23, 2025, 4:00 PM AEST
LTR Pharma Market Cap
LTR Pharma has a market cap or net worth of 76.01 million as of July 22, 2025. Its market cap has decreased by -35.86% in one year.
Market Cap
76.01M
Enterprise Value
41.94M
Revenue
499.71K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.39
Market Cap Chart
Since December 11, 2023, LTR Pharma's market cap has increased from 52.98M to 76.01M, an increase of 43.47%. That is a compound annual growth rate of 25.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2025 | 76.01M | -48.15% |
| Dec 31, 2024 | 146.59M | 204.77% |
| Dec 29, 2023 | 48.10M | -9.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 124.63B |
| Pro Medicus | 34.26B |
| Cochlear | 20.29B |
| Sonic Healthcare | 13.65B |
| Ramsay Health Care | 8.93B |
| Telix Pharmaceuticals | 8.55B |
| Ansell | 4.49B |
| Mesoblast | 3.08B |